| 000 | 01628 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514161407.0 | ||
| 264 | 0 | _c20040623 | |
| 008 | 200406s 0 0 eng d | ||
| 022 | _a1521-6926 | ||
| 024 | 7 |
_a10.1016/s1521-6926(03)00066-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSonneveld, Pieter | |
| 245 | 0 | 0 |
_aImmunophenotyping as a guide for targeted therapy. _h[electronic resource] |
| 260 |
_bBest practice & research. Clinical haematology _cDec 2003 |
||
| 300 |
_a629-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAntigens, CD _ximmunology |
| 650 | 0 | 4 |
_aAntigens, Differentiation, Myelomonocytic _ximmunology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple _xgenetics |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunophenotyping _xmethods |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSialic Acid Binding Ig-like Lectin 3 |
| 650 | 0 | 4 | _afms-Like Tyrosine Kinase 3 |
| 700 | 1 | _aPieters, Rob | |
| 773 | 0 |
_tBest practice & research. Clinical haematology _gvol. 16 _gno. 4 _gp. 629-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1521-6926(03)00066-5 _zAvailable from publisher's website |
| 999 |
_c14330850 _d14330850 |
||